Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 6, 2008, Pages 542-548

  Diz, Debra I ^a   Garcia Espinosa, Maria Antonia ^a   Gallagher, Patricia E ^a   Ganten, Detlev ^b   Ferrario, Carlos M ^a   Averill, David B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiotensins; Baroreceptor reflex; Cardiac vagal chemosensitive fiber activation; Control of heart rate; Phenylbiguanide; Transgenic rats

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR MAS; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; PHENYLBIGUANIDE; PHENYLEPHRINE; UNCLASSIFIED DRUG; 7 ALA ANGIOTENSIN (1 7); 7-ALA-ANGIOTENSIN (1-7); ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); ANTIHYPERTENSIVE AGENT; BIGUANIDE DERIVATIVE; DRUG DERIVATIVE; PEPTIDE FRAGMENT; REN2 PROTEIN, MOUSE; RENIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ATTENUATION; BOLUS INJECTION; BRAIN; CARDIOVASCULAR EFFECT; CHEMOSENSITIVE AFFERENT FIBER ACTIVATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; GENE OVEREXPRESSION; HEART RATE; INJECTION; MALE; MEDULLA OBLONGATA; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RAT STRAIN; SENSORY NERVE CELL; SOLITARY TRACT NUCLEUS; TRANSGENIC RAT; VAGUS REFLEX; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC ANIMAL;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BIGUANIDES; BLOOD PRESSURE; FEMALE; HEART RATE; MALE; MICE; PEPTIDE FRAGMENTS; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SOLITARY NUCLEUS;

EID: 53249156551     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181734a54     Document Type: Article

References (48)

1. Benter IF, Diz DI, Ferrario CM. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension. 1995;26:1138-1144.
2. Chaves GZ, Caligiorne SM, Santos RA, et al. Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats. J Hypertension. 2000;18:1841-1848.
3. Campagnole-Santos MJ, Heringer SB, Batista EN, et al. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol. 1992;263:R89-R94.
4. Santos RAS, Campagnole-Santos MJ, Baracho NCV, et al. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): Evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994;35:293-298.
5. Oliveira DR, Santos RA, Santos GF, et al. Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension. 1996;27:1284-1290.
6. Sakima A, Averill DB, Gallagher PE, et al. Impaired heart rate baroreflex in older rats. Role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension. 2005;46:333-340.
7. Sakima A, Averill DB, Kasper SO, et al. Baroreceptor reflex regulation in anesthetized transgenic rats with low glial-derived angiotensinogen. Am J Physiol. 2007;292:H1412-H1419.
8. Britto RR, Santos RA, Fagundes-Moura CR, et al. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension. 1997;30:549-556.
9. Iyer SN, Chappell MC, Averill DB, et al. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension. 1998;31:699-705.
10. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 1998;31:356-361.
11. Matsumura K, Averill DB, Ferrario CM. Angiotensin II acts at AT 1receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol. 1998;275:R1611-R1619.
12. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
13. Moriguchi A, Brosnihan KB, Kumagai H, et al. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1279.
14. Senanayake PD, Moriguchi A, Kumagai H, et al. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
15. Groban L, Ferrario C, Ganten D, et al. Transgenic rats with low brainenin-angiotensin system activity due to glial deficiency are protected against heart failure late in life. J Cardiac Failure. 2007;13:S83.
16. Fontes MA, Baltatu O, Caligiorne SM, et al. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats. Physiol Genomics. 2000;2:137-142.
17. Aileru AA, Logan E, Callahan M, et al. Alterations in sympathetic ganglionic transmission in response to angiotensin II in (mRen2)27 transgenic rats. Hypertension. 2004;43:270-275.
18. Moriguchi A, Tallant EA, Matsumura K, et al. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995;25:1260-1265.
19. Dobruch J, Paczwa P, Lon S, et al. Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats. J Physio Pharm. 2003;54:371-381.
20. Garcia-Espinosa MA, Gallagher PE, Ganten D, et al. Intracisternal injection of angiotensin-(1-7)-producing fusion protein plasmid lowers blood pressure in hypertensive (mren2)27 rats. Hypertension 2006;48:e87.
21. Diz DI, Jessup JA, Westwood BM, et al. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exper Pharmacol Physiol.2001;29:473-482.
22. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides. 1993;14:679-684.
23. Arnold AC, Sakima A, Ganten D, et al. Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen. Hypertension. 2008; 51: in press.
24. Campagnole-Santos MJ, Diz DI, Ferrario CM. Baroreflex reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension. 1988;11(Suppl I):I167-I171.
25. Campagnole-Santos MJ, Diz DI, Santos RAS, et al. Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol. 1989;257:H324-H329.
26. Fow JE, Averill DB, Barnes KL. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol. 1994;267:H259-H266.
27. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd Ed. Orlando: Academic Press; 1986.
28. Diz DI, Westwood B, Averill DB. AT1 antisense distinguishes receptors mediating angiotensin II actions in solitary tract nucleus. Hypertension. 2001;37:1292-1297.
29. Kasper SO, Ferrario CM, Ganten D, et al. Central depletion of angiotensinogen is associated with elevated AT1 receptors in the SFO and PVN. Neurotoxicity Res. 2004;6:259-265.
30. Diz DI, Ferrario CM. Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1-7). In: Sumners PR, ed. Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors. New York: Plenum Press; 1996:225-235.
31. Gallagher PE, Li P, Lenhart JR, et al. Estrogen regulation of angiotensinconverting enzyme mRNA. Hypertension. 1999;33:323-329.
32. Diz DI, Westwood BM, Bosch SM, et al. NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata. Hypertension. 1998;31:473-479.
33. Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull. 2001;51:119-128.
34. Borgonio A, Pummer S, Witte K, et al. Reduced baroreflex sensitivity and blunted endogenous nitric oxide synthesis precede the development of hypertension in TGR(mREN2)27 rats. Chronobiol Int. 2001;18:215-226.
35. Garcia-Espinosa MA, Chappell MC, Ganten D, et al. Chronic intracerebroventricular AT1 receptor blockade, but not renin inhibition,normalizes blood pressure in (mRen2)27 transgenic rats. FASEB J. 2008; 22:953-10.
36. Brooks VL. Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism. Hypertension. 1995;26:420-424.
37. Morimoto S, Cassell MD, Sigmund CD. Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem. 2002;277:33235-33241.
38. Sakai K, Chapleau MW, Morimoto S, et al. Differential modulation of baroreflex control of heart rate by neuron-vs. glia-derived angiotensin II. Physiol Genomics. 2004;20:66-72.
39. Fontes MAP, Pinge MCM, Naves V, et al. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res. 1997;750: 305-310.
40. Moriguchi A, Ferrario CM, Brosnihan KB, et al. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol. 1994;267:R786-R791.
41. Diz DI, Falgui B, Bosch SM, et al. Hypothalamic substance P release: attenuated angiotensin responses in mRen2(27) transgenic rats. Hypertension. 1997;29:510-513.
42. Iyer SN, Yamada K, Diz DI, et al. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovas Pharmacol. 2000;36: 109-117.
43. Chappell MC, Tallant EA, Diz DI, et al. The renin-angiotensin system and cardiovascular homeostasis. In: Husain A, Graham R, eds. Drugs, Enzymes and Receptors of the Renin Angiotensin System: Celebrating a Century of Discovery. Harwood Academic Publishers; 2000:3-21.
44. Tallant EA, Diz DI, Ferrario CM. Characterization of angiotensin receptors. In: Greenstein B, ed. Research Receptor Methods. Switzerland: Harwood Academic Publishers; 1995:109-132.
45. Diz DI, Tommasi EN, Ferrario CM, et al. ACE2 inhibition in the nucleus of the solitary tract reduces baroreceptor reflex sensitivity. Hypertension 2006;48:e87
46. Farah VM, Moreira ED, Irigoyen MC, et al. Baroreflex depression persists in the early phase after hypertension reversal. Am J Physiol. 2001;280: R1620-R1626.
47. Krieger EM. Time course of baroreceptor resetting in acute hypertension. Am J Physiol. 1970;218:486-90.
48. Moreira ED, Ida F, Krieger EM. Reversibility of baroreceptor hyposensitivity during reversal of hypertension. Hypertension. 1990;15: 791-796.